DiaMedica Therapeutics Inc. (DMAC) Investor Relations Documents

DiaMedica Therapeutics Inc. (DMAC) investor relations documents from the company's IR site: 4 presentations, 33 press releases; latest deck 2026-07-16. Read in-app with summaries. First-party data.

DiaMedica Corporate Presentation: DiaMedica Therapeutics is developing DM199, a recombinant KLK1 protein, to treat preeclampsia, fetal growth restriction, and acute ischemic stroke.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseDiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
2026-08-04Press releaseDiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
2026-07-17Press releaseDiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-16PresentationDiaMedica Corporate Presentation
2026-06-23Press releaseDiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restri
2026-06-16Press releaseDiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
2026-05-27Press releaseDiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
2026-05-20Press releaseDiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
2026-05-12Press releaseDiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
2026-05-07Press releaseDiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
2026-04-30Press releaseDiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
2026-04-24Presentationhttps://d1io3yog0oux5.cloudfront.net/_3daddff1be173e5054da404516d1b7e4/diamedica/db/202/3317/pdf/DiaMedica+Corporate+Presentation+-+April+2026.pdf
2026-04-01Proxy statement2025 Annual Report
2026-03-31Press releaseDiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
Press releaseDiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
Press releaseDiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Press releaseDiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
Press releaseDiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
Press releaseDiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Press releaseDiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025
2025-07-17PresentationClick this link to view the presentation
Press releaseDiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
Press releaseDiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
2025-03-21Proxy statement2024 Annual Report
2025-03-18Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
2025-03-11Press releaseDiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
2024-11-14PresentationReMEDy2 Update
2024-11-14Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
2024-11-06Press releaseDiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
2024-08-08Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
2024-08-01Press releaseDiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024
2024-05-09Press releaseDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
2024-05-02Press releaseDiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
2023-11-14Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
2023-11-06Press releaseDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
2023-08-15Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
2023-05-16Press releaseDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
2023-05-08Press releaseDiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
2023-03-29Press releaseDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
2023-03-28Proxy statement2022 Annual Report

DMAC overview · DMAC earnings · DMAC financials · DMAC KPIs · DMAC ownership · DMAC peers · DMAC filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.